Insider linked to Colgate-Palmolive (CL) plans $9.2M Rule 144 stock sale after option exercise

Rhea-AI Filing Summary

Colgate-Palmolive common stock is being prepared for sale under Rule 144 following an option exercise. A holder plans to sell 97,843 shares of Colgate-Palmolive common stock through Merrill Lynch on the NYSE, with an aggregate market value of $9,223,283.80.

The shares were acquired on 02/04/2026 via an exercise of employee stock options in a broker-assisted cashless transaction, with payment made the same day. Colgate-Palmolive had 806,064,942 shares of common stock outstanding, providing context for the size of this planned sale under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	97843	9223283.80	806064942	02/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/04/2026	Exercise of employee stock options	COLGATE PALMOLIVE CO			97843	02/04/2026	Broker assisted cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for Colgate-Palmolive (CL) disclose?

The filing discloses a planned Rule 144 sale of 97,843 Colgate-Palmolive common shares with an aggregate market value of $9,223,283.80, following an employee stock option exercise and broker-assisted cashless transaction on 02/04/2026.

How many Colgate-Palmolive (CL) shares are planned to be sold under this Form 144?

The notice covers a planned sale of 97,843 shares of Colgate-Palmolive common stock. These shares are to be sold on the NYSE through Merrill Lynch, as disclosed in the Rule 144 filing’s securities information table.

What is the aggregate market value of the Colgate-Palmolive (CL) shares in this Rule 144 filing?

The aggregate market value of the Colgate-Palmolive common stock covered by this planned Rule 144 sale is $9,223,283.80. This value is based on 97,843 shares identified in the securities information table in the filing.

How and when were the Colgate-Palmolive (CL) shares acquired for this Form 144 sale?

The 97,843 Colgate-Palmolive common shares were acquired on 02/04/2026 through the exercise of employee stock options. The filing states this occurred via a broker-assisted cashless exercise, with payment on the same date.

On which exchange will the Colgate-Palmolive (CL) Rule 144 shares be sold?

The filing indicates the Colgate-Palmolive common stock covered by this Rule 144 notice is intended for sale on the NYSE. Merrill Lynch, located at 225 Liberty Street, New York, is listed as the broker for these transactions.

How many Colgate-Palmolive (CL) shares were outstanding for context in this filing?

The securities table reports 806,064,942 Colgate-Palmolive common shares outstanding. This figure provides context for evaluating the relative size of the 97,843-share planned sale under Rule 144 disclosed in the notice.